KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
002099 Zhejiang Hisoar Pharmaceutical
- 5.73
- -0.21-3.54%
Market Closed Dec 13 15:00 CST
9.28BMarket Cap-25.13P/E (TTM)
5.94High5.72Low166.38KlotVolume5.93Open5.94Pre Close96.30MTurnover1.03%Turnover RatioLossP/E (Static)1.62BShares7.3352wk High1.70P/B9.26BFloat Cap3.9152wk Low6.53Limit Up1.62BShs Float17.62Historical High5.35Limit Down3.70%Amplitude-0.28Historical Low--Dividend TTM5.79Avg Price113.34KlotAsk--Div YieldTTM100Lot Size48.95KlotBid
Zhejiang Hisoar Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -13.85%1.44B | -13.17%1.04B | -16.65%528.46M | -19.68%2.17B | -19.05%1.68B | -18.49%1.2B | -21.19%634.05M | 8.83%2.7B | 15.63%2.07B | 23.46%1.47B |
| Operating revenue | -13.85%1.44B | -13.17%1.04B | -16.65%528.46M | -19.68%2.17B | -19.05%1.68B | -18.49%1.2B | -21.19%634.05M | 8.83%2.7B | 15.63%2.07B | 23.46%1.47B |
| Other operating revenue | ---- | 40.48%11.49M | ---- | 43.04%9.14M | ---- | 400.64%8.18M | ---- | -20.00%6.39M | ---- | -61.07%1.63M |
| Total operating cost | -17.08%1.38B | -15.07%962.35M | -29.52%452.55M | -5.77%2.33B | -7.61%1.66B | -10.89%1.13B | -9.30%642.13M | 4.62%2.48B | 4.42%1.8B | 12.39%1.27B |
| Operating cost | -22.36%1.05B | -21.75%746.61M | -28.59%362.06M | -5.88%1.87B | -7.55%1.35B | -6.35%954.19M | -9.99%507.04M | 27.22%1.98B | 30.99%1.46B | 40.12%1.02B |
| Operating tax surcharges | -4.01%19.64M | -6.08%12.76M | 3.37%6.27M | 30.47%27.76M | 32.83%20.46M | 28.97%13.59M | 3.43%6.06M | -20.42%21.28M | -20.55%15.4M | -23.49%10.53M |
| Operating expense | 7.77%22.61M | 4.43%14.07M | 10.46%5.27M | 11.18%29.22M | 19.54%20.98M | 20.21%13.47M | -11.57%4.77M | -1.64%26.28M | -5.77%17.55M | 15.41%11.2M |
| Administration expense | -6.86%211.6M | -0.47%144.13M | -8.14%62.69M | -19.27%324.87M | -31.65%227.19M | -33.38%144.81M | -28.00%68.24M | -29.31%402.44M | -24.12%332.41M | -25.00%217.37M |
| Financial expense | 53.46%-25.48M | 65.34%-19.44M | -155.09%-13.75M | 69.44%-31.32M | 61.24%-54.75M | 4.34%-56.08M | 547.97%24.96M | -607.29%-102.48M | -7,230.61%-141.25M | -783.86%-58.62M |
| -Interest expense (Financial expense) | -14.76%22.98M | 4.99%18.71M | 88.17%11.17M | 3.33%37.76M | 10.81%26.95M | 2.20%17.82M | 22.47%5.94M | 66.99%36.55M | 90.09%24.32M | 59.98%17.44M |
| -Interest Income (Financial expense) | 23.08%-44.52M | 38.60%-25.55M | -105.94%-19.66M | -103.54%-68.13M | -195.84%-57.88M | -161.12%-41.61M | -141.26%-9.54M | -1.42%-33.47M | 15.73%-19.57M | 0.45%-15.94M |
| Research and development | 4.74%97.7M | 1.80%64.22M | -3.32%30.01M | -20.25%115.56M | -14.55%93.28M | -12.49%63.09M | -10.70%31.04M | -11.98%144.91M | -12.84%109.16M | -12.38%72.09M |
| Credit Impairment Loss | -84.03%3.21M | -120.22%-2.57M | -96.35%407.05K | 176.54%13.41M | 958.83%20.13M | 333.38%12.73M | 371.20%11.16M | -73.78%-17.53M | 31.84%-2.34M | 22.34%-5.46M |
| Asset Impairment Loss | ---93.57M | ---49.77M | ---47.65M | -183.95%-237.86M | ---- | ---- | ---- | -676.32%-83.77M | ---- | ---- |
| Other net revenue | -8.37%-67.05M | 9.22%-41.28M | -189.56%-46.91M | -155.65%-302.79M | -57.14%-61.87M | -4,707.11%-45.48M | 1,331.18%52.38M | -2,925.45%-118.44M | -270.18%-39.37M | -93.26%987.07K |
| Fair value change income | 100.77%336.07K | 110.54%6.76M | ---- | -432.34%-104.25M | 9.15%-43.8M | -1,365.09%-64.16M | 687.33%9.26M | -402.93%-19.58M | -464.86%-48.21M | -132.01%-4.38M |
| Invest income | 111.00%6.76M | 42.43%-7.06M | -129.99%-6.03M | 41.24%-13.37M | -1,670.11%-61.42M | -800.04%-12.26M | 244.93%20.09M | -781.98%-22.75M | -200.16%-3.47M | 555.93%1.75M |
| -Including: Investment income associates | 20.94%-6.93M | 42.47%-5.14M | -27.25%-3.87M | 48.91%-16.84M | 10.99%-8.77M | -30.22%-8.93M | -0.47%-3.04M | -286.34%-32.97M | -254.05%-9.85M | -189.24%-6.86M |
| Asset deal income | -94.43%547.93K | -96.53%365.09K | -97.21%231.69K | 4,326.85%12.88M | 1,926.27%9.84M | 2,950.15%10.53M | 5,023.79%8.3M | 119.64%290.87K | 1.68%485.41K | -27.67%345.32K |
| Other revenue | 17.14%15.67M | 43.20%10.99M | 71.87%6.13M | 6.06%26.41M | -5.54%13.38M | -12.01%7.68M | 5.91%3.56M | 48.68%24.9M | 40.30%14.16M | 33.27%8.73M |
| Operating profit | 103.87%1.72M | 96.70%35.21M | -34.52%29.01M | -524.36%-464.24M | -118.80%-44.36M | -90.93%17.9M | -55.78%44.3M | -10.36%109.4M | 149.57%236.01M | 173.18%197.33M |
| Add:Non operating Income | 6,028.47%2.05M | 2,933.32%1.58M | 6,373.93%1.02M | -84.09%243.96K | -96.48%33.4K | -94.95%52.14K | -97.98%15.7K | -37.86%1.53M | -70.79%948.19K | -54.66%1.03M |
| Less:Non operating expense | -51.85%675.88K | -68.19%287.25K | -19.98%196.06K | -78.04%2.22M | 32.87%1.4M | 1,322.93%902.99K | 96.56%245.03K | 585.03%10.13M | -58.51%1.06M | -96.21%63.46K |
| Total profit | 106.75%3.09M | 114.11%36.5M | -32.32%29.83M | -562.51%-466.22M | -119.38%-45.73M | -91.40%17.05M | -56.30%44.07M | -18.07%100.8M | 147.63%235.9M | 172.26%198.3M |
| Less:Income tax cost | -14.38%-7.15M | 84.27%-218.95K | -202.14%-2.27M | -403.17%-44.64M | -120.84%-6.25M | -105.06%-1.39M | -84.46%2.22M | -49.51%14.73M | 51.66%29.98M | 110.32%27.5M |
| Net profit | 125.92%10.23M | 99.14%36.72M | -23.30%32.1M | -589.77%-421.58M | -119.17%-39.48M | -89.20%18.44M | -51.65%41.85M | -8.30%86.08M | 172.76%205.92M | 185.81%170.8M |
| Net profit from continuing operation | 125.92%10.23M | 99.14%36.72M | -23.30%32.1M | -589.77%-421.58M | -119.17%-39.48M | -89.20%18.44M | -51.65%41.85M | -8.30%86.08M | 172.76%205.92M | 185.81%170.8M |
| Less:Minority Profit | -95.83%-1.75M | -88.73%-1.38M | -95.86%-495.53K | 21.20%-1.53M | 25.34%-891.29K | 14.95%-733.19K | 46.90%-253K | -42.12%-1.94M | -2.48%-1.19M | -15.35%-862.11K |
| Net profit of parent company owners | 131.05%11.98M | 98.74%38.1M | -22.58%32.59M | -577.26%-420.06M | -118.63%-38.59M | -88.83%19.17M | -51.62%42.1M | -7.58%88.01M | 170.17%207.12M | 183.71%171.66M |
| Earning per share | ||||||||||
| Basic earning per share | 150.00%0.01 | 100.00%0.02 | 0.00%0.02 | -620.00%-0.26 | -115.38%-0.02 | -90.91%0.01 | -60.00%0.02 | -16.67%0.05 | 160.00%0.13 | 175.00%0.11 |
| Diluted earning per share | 150.00%0.01 | 100.00%0.02 | 0.00%0.02 | -620.00%-0.26 | -115.38%-0.02 | -90.91%0.01 | -60.00%0.02 | -16.67%0.05 | 160.00%0.13 | 175.00%0.11 |
| Other composite income | -115.03%-634.72K | 1,513.22%4.22M | 36.40%-293.47K | |||||||
| Other composite income of parent company owners | ---- | ---- | ---- | -115.03%-634.72K | ---- | ---- | ---- | 1,513.22%4.22M | 36.40%-293.47K | ---- |
| Total composite income | 125.92%10.23M | 99.14%36.72M | -23.30%32.1M | -567.56%-422.22M | -119.20%-39.48M | -89.20%18.44M | -51.65%41.85M | -3.49%90.3M | 174.04%205.63M | 185.09%170.8M |
| Total composite income of parent company owners | 131.05%11.98M | 98.74%38.1M | -22.58%32.59M | -556.10%-420.69M | -118.66%-38.59M | -88.83%19.17M | -51.62%42.1M | -2.84%92.24M | 171.42%206.82M | 183.00%171.66M |
| Total composite income of minority owners | -95.83%-1.75M | -88.73%-1.38M | -95.86%-495.53K | 21.20%-1.53M | 25.34%-891.29K | 14.95%-733.19K | 46.90%-253K | -42.12%-1.94M | -2.48%-1.19M | -15.35%-862.11K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
